Header Logo

Connection

TETSUO ASHIZAWA to Genetic Therapy

Back to Details
This is a "connection" page, showing publications TETSUO ASHIZAWA has written about Genetic Therapy.
TETSUO ASHIZAWA
Connection Strength
0.311
Genetic Therapy
  1. Emerging therapies in hereditary ataxias. Trends Mol Med. 2025 Feb; 31(2):181-194.
    View in: PubMed
    Score: 0.167
  2. Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy. Mol Ther. 2016 08; 24(8):1378-87.
    View in: PubMed
    Score: 0.094
  3. Therapeutic Genome Editing for Myotonic Dystrophy Type 1?Using CRISPR/Cas9. Mol Ther. 2018 Nov 07; 26(11):2617-2630.
    View in: PubMed
    Score: 0.028
  4. Emerging therapies in Friedreich's ataxia. Neurodegener Dis Manag. 2016; 6(1):49-65.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.